Scarica l'app Stockscreener
1.75
0.57%
0.01
Pre-mercato:
1.75
Precedente Chiudi:
$1.74
Aprire:
$1.74
Volume 24 ore:
274.39K
Relative Volume:
0.24
Capitalizzazione di mercato:
$141.21M
Reddito:
-
Utile/perdita netta:
$-117.50M
Rapporto P/E:
-0.7292
EPS:
-2.4
Flusso di cassa netto:
$-114.31M
1 W Prestazione:
+1.16%
1M Prestazione:
-1.13%
6M Prestazione:
-30.00%
1 anno Prestazione:
-67.32%
Intervallo 1D:
$1.74
$1.79
Intervallo di 1 settimana:
$1.63
$1.795
Portata 52W:
$1.31
$8.23
Nkarta Inc Stock (NKTX) Company Profile
Nome
Nkarta Inc
Settore
Industria
Telefono
(925) 407-1049
Indirizzo
1150 VETERANS BOULEVARD, SOUTH SAN FRANCISCO
Confronta NKTX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NKTX
Nkarta Inc
|
1.75 | 141.21M | 0 | -117.50M | -114.31M | -2.40 |
|
VRTX
Vertex Pharmaceuticals Inc
|
459.62 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
547.36 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
331.91 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
543.48 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
245.49 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Nkarta Inc Stock (NKTX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-15 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2024-10-09 | Iniziato | Rodman & Renshaw | Buy |
| 2024-08-14 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2024-03-22 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2022-12-22 | Downgrade | Oppenheimer | Outperform → Perform |
| 2022-10-10 | Iniziato | Canaccord Genuity | Buy |
| 2022-07-28 | Iniziato | Needham | Buy |
| 2022-07-18 | Iniziato | SVB Leerink | Outperform |
| 2022-03-11 | Iniziato | Raymond James | Outperform |
| 2022-03-08 | Iniziato | H.C. Wainwright | Buy |
| 2022-01-06 | Iniziato | William Blair | Outperform |
| 2021-11-18 | Iniziato | SMBC Nikko | Outperform |
| 2021-07-16 | Iniziato | Oppenheimer | Outperform |
| 2020-08-04 | Iniziato | Cowen | Outperform |
| 2020-08-04 | Iniziato | Evercore ISI | Outperform |
| 2020-08-04 | Iniziato | Mizuho | Buy |
| 2020-08-04 | Iniziato | Stifel | Buy |
Mostra tutto
Nkarta Inc Borsa (NKTX) Ultime notizie
Nkarta (NASDAQ:NKTX) Price Target Lowered to $14.00 at Mizuho - Defense World
Nkarta (NKTX) Maintains Outperform Rating as Mizuho Lowers Price Target | NKTX Stock News - GuruFocus
Two Sigma Investments LP Reduces Position in Nkarta, Inc. (NASDAQ:NKTX) - Defense World
Nkarta price target lowered to $14 from $16 at Mizuho - TipRanks
Nkarta (NKTX) Price Target Reduced by Mizuho | NKTX Stock News - GuruFocus
Nkarta, Inc. (NASDAQ:NKTX) Receives Consensus Recommendation of “Buy” from Analysts - Defense World
Nkarta, Inc. (NASDAQ:NKTX) Shares Bought by Wellington Management Group LLP - Defense World
Bank of America Corp DE Grows Stock Holdings in Nkarta, Inc. (NASDAQ:NKTX) - Defense World
Two Sigma Advisers LP Acquires New Stake in Nkarta, Inc. (NASDAQ:NKTX) - Defense World
Nkarta Names Shawn Rose as Chief Medical Officer - marketscreener.com
Nkarta Announces Leadership Change with New CMO - TipRanks
Nkarta appoints Shawn Rose as CMO, head of R&D - TipRanks
Nkarta Appoints Shawn Rose Chief Medical Officer & Head of - GlobeNewswire
Nkarta Taps Sotyktu, Stelara Developer as New CMO to Lead Autoimmune Disease Push - Stock Titan
Nkarta, Inc. (NASDAQ:NKTX) Shares Bought by Nuveen Asset Management LLC - Defense World
ProShare Advisors LLC Invests $45,000 in Nkarta, Inc. (NASDAQ:NKTX) - Defense World
Deutsche Bank AG Has $107,000 Stock Position in Nkarta, Inc. (NASDAQ:NKTX) - Defense World
Millennium Management LLC Boosts Position in Nkarta, Inc. (NASDAQ:NKTX) - Defense World
BNP Paribas Financial Markets Invests $507,000 in Nkarta, Inc. (NASDAQ:NKTX) - Defense World
Nkarta (NKTX) Moves to Buy: Rationale Behind the Upgrade - MSN
Equities Analysts Issue Forecasts for Nkarta FY2025 Earnings - Defense World
Leerink Partnrs Analysts Lower Earnings Estimates for Nkarta - Defense World
Price T Rowe Associates Inc. MD Acquires 7,030 Shares of Nkarta, Inc. (NASDAQ:NKTX) - Defense World
William Blair Comments on Nkarta’s Q2 Earnings (NASDAQ:NKTX) - Defense World
Nkarta (NASDAQ:NKTX) Earns “Market Perform” Rating from William Blair - Defense World
Needham & Company LLC Lowers Nkarta (NASDAQ:NKTX) Price Target to $10.00 - Defense World
Analysts Offer Insights on Healthcare Companies: Organon (OGN), Diamedica Therapeutics (DMAC) and Nkarta (NKTX) - The Globe and Mail
Dimensional Fund Advisors LP Has $1.42 Million Stock Position in Nkarta, Inc. (NASDAQ:NKTX) - Defense World
Nkarta, Inc. (NASDAQ:NKTX) Shares Bought by Stifel Financial Corp - Defense World
Nkarta, Inc. (NASDAQ:NKTX) Given Consensus Rating of “Buy” by Analysts - Defense World
Nkarta, Inc. Reports Q1 2025 Financial Results - TipRanks
Nkarta stock rating downgraded at William Blair to Market Perform By Investing.com - Investing.com South Africa
Nkarta Downgraded, Analyst Cites Competitive Pressure In Autoimmune Space - Benzinga
Nkarta (NKTX) Experiences Downgrade Amid Clinical Protocol Changes | NKTX Stock News - GuruFocus
NKTX's Strategic Moves to Reach Clinical Milestones and Extend C - GuruFocus
NKTX: William Blair Downgrades Nkarta to Market Perform | NKTX S - GuruFocus
Needham Maintains 'Buy' Rating on Nkarta (NKTX) as Price Target Adjusts | NKTX Stock News - GuruFocus
This Alcoa Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday - Benzinga
NKTX: William Blair Downgrades Nkarta to Market Perform | NKTX Stock News - GuruFocus
William Blair Downgrades Nkarta to Market Perform From Outperform - marketscreener.com
Nkarta stock rating downgraded at William Blair to Market Perform - Investing.com
Nkarta Reports First Quarter 2025 Financial Results and Corporate Highlights - GlobeNewswire
NKTX's Strategic Moves to Reach Clinical Milestones and Extend Cash Runway | NKTX Stock News - GuruFocus
Nkarta's $351.9M War Chest Funds Operations Until 2029 as Clinical Trials Expand in Autoimmune Diseases - Stock Titan
Nkarta, Inc. (NASDAQ:NKTX) Shares Acquired by Wells Fargo & Company MN - Defense World
Barclays PLC Has $674,000 Stock Holdings in Nkarta, Inc. (NASDAQ:NKTX) - Defense World
Financial Snapshot: Analyzing Nkarta Inc (NKTX)’s Key Ratio Metrics - DWinneX
11,997 Shares in Nkarta, Inc. (NASDAQ:NKTX) Purchased by Invesco Ltd. - Defense World
Uncovering the Potential of Nkarta Inc (NKTX) Stock - investchronicle.com
A stock that deserves closer examination: Nkarta Inc (NKTX) - uspostnews.com
Nkarta Inc (NKTX) may enjoy gains as insiders got busy in the recent days - knoxdaily.com
Nkarta Inc Azioni (NKTX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Nkarta Inc Azioni (NKTX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Shook David | See Remarks |
Jan 15 '25 |
Sale |
2.20 |
8,638 |
19,004 |
190,955 |
| Levin Alyssa | See Remarks |
Jan 15 '25 |
Sale |
2.20 |
5,838 |
12,844 |
102,662 |
| Brandenberger Ralph | Chief Technical Officer |
Jan 15 '25 |
Sale |
2.20 |
7,447 |
16,383 |
124,796 |
| HASTINGS PAUL J | Chief Executive Officer |
Jan 15 '25 |
Sale |
2.20 |
17,378 |
38,232 |
319,859 |
| Hager Alicia J. | Chief Legal Officer |
Jan 15 '25 |
Sale |
2.20 |
9,584 |
21,085 |
146,735 |
| Hager Alicia J. | Chief Legal Officer |
Jul 16 '24 |
Sale |
8.00 |
3,396 |
27,168 |
103,819 |
0.68%
0.50%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):